Streetbeat News

Price Targets

SRPT

Needham analyst Gil Blum has reiterated a Buy rating on Sarepta Therapeutics (NASDAQ:SRPT) and maintained a price target of $205.

Portfolio Pulse from Benzinga Newsdesk

October 14, 2024 | 10:46 am

VYX

Needham analyst Mayank Tandon has reiterated a Buy rating on NCR Voyix (NYSE:VYX) and maintained a price target of $20.

Portfolio Pulse from Benzinga Newsdesk

October 14, 2024 | 10:41 am

ADMA

HC Wainwright & Co. has reiterated its Buy rating on ADMA Biologics, maintaining a price target of $18. Analyst Raghuram Selvaraju continues to support the stock, indicating confidence in its potential.

Portfolio Pulse from Benzinga Newsdesk

October 14, 2024 | 10:38 am

RLAY

HC Wainwright & Co. has reiterated its Buy rating for Relay Therapeutics, maintaining a price target of $19. This suggests confidence in the company's future performance.

Portfolio Pulse from Benzinga Newsdesk

October 14, 2024 | 10:29 am

MIST

HC Wainwright & Co. analyst Patrick Trucchio has reiterated a Buy rating for Milestone Pharmaceuticals (NASDAQ:MIST) and maintained a $25 price target.

Portfolio Pulse from Benzinga Newsdesk

October 14, 2024 | 10:19 am

ALKS

HC Wainwright & Co. has reiterated a Neutral rating for Alkermes (NASDAQ:ALKS) and maintained a price target of $37.

Portfolio Pulse from Benzinga Newsdesk

October 14, 2024 | 10:11 am

BROS

Wedbush analyst Nick Setyan has reiterated an Outperform rating for Dutch Bros (NYSE:BROS) and maintained a price target of $45.

Portfolio Pulse from Benzinga Newsdesk

October 14, 2024 | 10:07 am

EXPD

TD Cowen has downgraded Expeditors Intl from Hold to Sell and reduced its price target from $112 to $106.

Portfolio Pulse from Benzinga Newsdesk

October 14, 2024 | 9:51 am

ARCB

TD Cowen has downgraded ArcBest from Buy to Hold and reduced its price target from $131 to $114.

Portfolio Pulse from Benzinga Newsdesk

October 14, 2024 | 9:46 am

ASTH

TD Cowen has initiated coverage on Astrana Health with a Buy rating and set a price target of $66.

Portfolio Pulse from Benzinga Newsdesk

October 14, 2024 | 9:39 am